Perturbation of glucose flux in the liver by decreasing F26P<sub>2</sub>levels causes hepatic insulin resistance and hyperglycemia

American Journal of Physiology - Endocrinology and Metabolism - Tập 291 Số 3 - Trang E536-E543 - 2006
Chaodong Wu1, Salmaan Khan, Li-Jen Peng2, Honggui Li2, Steven G. Carmella3, Alex J. Lange4
1Department of Biochemistry Molecular Biology, and Biophysics, University of Minnesota Minneapolis, MN, 55455, USA
2University of Minnesota Twin Cities
3Carcinogenesis and Chemoprevention
4Metabolic and Systems Biology (TMED)

Tóm tắt

Hepatic insulin resistance is one of the characteristics of type 2 diabetes and contributes to the development of hyperglycemia. How changes in hepatic glucose flux lead to insulin resistance is not clearly defined. We determined the effects of decreasing the levels of hepatic fructose 2,6-bisphosphate (F26P2), a key regulator of glucose metabolism, on hepatic glucose flux in the normal 129J mice. Upon adenoviral overexpression of a kinase activity-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, the enzyme that determines F26P2level, hepatic F26P2levels were decreased twofold compared with those of control virus-treated mice in basal state. In addition, under hyperinsulinemic conditions, hepatic F26P2levels were much lower than those of the control. The decrease in F26P2leads to the elevation of basal and insulin-suppressed hepatic glucose production. Also, the efficiency of insulin to suppress hepatic glucose production was decreased (63.3 vs. 95.5% suppression of the control). At the molecular level, a decrease in insulin-stimulated Akt phosphorylation was consistent with hepatic insulin resistance. In the low hepatic F26P2states, increases in both gluconeogenesis and glycogenolysis in the liver are responsible for elevations of hepatic glucose production and thereby contribute to the development of hyperglycemia. Additionally, the increased hepatic gluconeogenesis was associated with the elevated mRNA levels of peroxisome proliferator-activated receptor-γ coactivator-1α and phospho enolpyruvate carboxykinase. This study provides the first in vivo demonstration showing that decreasing hepatic F26P2levels leads to increased gluconeogenesis in the liver. Taken together, the present study demonstrates that perturbation of glucose flux in the liver plays a predominant role in the development of a diabetic phenotype, as characterized by hepatic insulin resistance.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.272.19.12854

10.1172/JCI112739

10.1210/me.2003-0357

10.2337/diab.37.6.667

10.1074/jbc.M405510200

El-Maghrabi MR, Pate TM, Murray KJ, and Pilkis SJ.Differential effects of proteolysis and protein modification on the activities of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.J Biol Chem259: 13096–13103, 1984.

10.1172/JCI115583

10.1074/jbc.M302134200

10.1152/ajpendo.00332.2002

10.1152/ajpendo.1995.269.6.E1037

10.1172/JCI2415

10.1016/S1097-2765(05)00015-8

10.1172/JCI200421270

10.1146/annurev.nutr.19.1.379

10.1016/S0968-0004(00)01699-6

10.1016/j.advenzreg.2003.11.006

10.2337/diabetes.54.7.1949

10.1146/annurev.bi.64.070195.004055

10.1146/annurev.bi.57.070188.003543

Pilkis SJ, El-Maghrabi MR, McGrane MM, Pilkis J, and Claus TH.The role of fructose 2,6-bisphosphate in regulation of fructose-1,6-bisphosphatase.J Biol Chem256: 11489–11495, 1981.

10.1016/j.cmet.2004.11.001

10.1038/nature01667

10.1074/jbc.271.1.203

10.1172/JCI114636

10.1172/JCI116681

10.1074/jbc.272.44.27758

10.1172/JCI119711

10.1074/jbc.M200964200

10.1172/JCI23187

10.1074/jbc.273.47.31615

10.1111/j.1432-1033.1982.tb07039.x

10.1016/j.cmet.2005.07.003

10.1152/ajpendo.2002.282.1.E38

10.1172/JCI11103

10.1210/en.2003-1290

Thông tin
Thông tin xuất bản

American Journal of Physiology - Endocrinology and Metabolism

Tập 291 Số 3

E536-E543

Thông tin tác giả